Publications by authors named "Steven Tyler"

Claim this Profile
N
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties.
Nilufer P Seth, Rui Xu, Matthew DuPrie, Amit Choudhury, Samuel Sihapong, Steven Tyler

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, Validation, and Implementation of a Guideline to Improve Clinical Event Debriefing at a Level-I Adult and Level-II Pediatric Trauma Center.
Steven Phillip Tyler, Jane Dixon, Janet Parkosewich, Paul C Mullan, Amish Aghera

J Emerg Nurs· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.
Daniel F Ortiz, Jonathan C Lansing, Laura Rutitzky, Elma Kurtagic, Thomas Prod'homme, Steven Tyler

Sci Transl Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.
Kristan Meetze, Sylvie Vincent, Steven Tyler, Elizabeth K Mazsa, Andrea R Delpero

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.
Nathaniel Washburn, Inessa Schwab, Daniel Ortiz, Naveen Bhatnagar, Jonathan C Lansing, Steven Tyler

Proc Natl Acad Sci U S A· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis